sunrise nov 1

peHUB First Read

After the weekend get up to speed on the latest happenings in the private equity universe with the lowdown on the Asian market, the CIA’s venture capital arm, JP Morgan ditching its PE unit and who’s coming and going in the world of biotech.

Reuters – Springer Science to Raise Nearly $1bn in IPO

German academic publisher Springer Science+Business Media is to raise about 760 million euros ($993 million) in a share offering, writes Reuters. The group said it planned to sell shares and list them on the Frankfurt stock exchange before the European summer break, and Goldman Sachs and JP Morgan were acting as joint global coordinators and joint bookrunners, writes Reuters.

CCC Backed by Leonard Green & Partners

Leonard Green & Partners is to acquire a controlling interest in CCC Information Services from Investcorp. CCC is a provider of advanced software and workflow tools to the insurance automotive claims and collision repair industries. Committed debt financing has been provided by certain affiliates of Goldman Sachs, including its principal mezzanine funds and J.P. Morgan.

NCR to Acquire Retalix

NCR Corporation is to acquire Retalix, a global provider of retail software and services, for a cash purchase price of $30.00 per Retalix share, or approximately $650 million in total. J.P. Morgan acted as exclusive financial advisor and Morrison & Foerster LLP and Amit, Pollak, Matalon & Co. acted as legal counsel to NCR on the transaction. Jefferies & Co acted as financial advisor and Meitar Liquornik Geva & Leshem Brandwein acted as legal counsel to Retalix Ltd. on the transaction.

Reuters – RIM Considers Splitting Business

BlackBerry maker Research in Motion is considering splitting its business in two, separating its struggling handset manufacturing division from its messaging network, The Sunday Times reported, writes Reuters. RIM last month said it had hired JP Morgan and RBC Capital to look at its strategic options. (Reuters) – BlackBerry maker Research in Motion is considering […]

Itron Acquires VC-backed SmartSynch

Itron, a provider of energy and water resource management solutions is to acquire Jackson, Mississippi-based SmartSynch in a $100 million transaction. SmartSynch is a provider of point-to-point smart grid solutions that use a cellular network for communications. Backers of the company include Kinetic Ventures, JP Morgan, Endeavor Capital Management, Nth Power, GulfSouth Capital, Siemens Venture […]

Lionsgate Acquires Summit

Global entertainment company Lionsgate is acquiring theatrical motion picture development, financing, production and distribution studio Summit Entertainment for $412.5 million. JP Morgan, Barclays Capital, and Jefferies served as joint lead arrangers and joint bookrunners on financing the acquisition for Lionsgate. PRESS RELEASE Lionsgate LGF (“the Company”) and Summit Entertainment today announced that Lionsgate has completed […]

Cognetas Gives up on Tokheim Sale

European private equity firm Cognetas has given up on the sale of French petrol station equipment provider Tokheim after offers failed to meet its price expectations, writes Reuters. Cognetas appointed JP Morgan to carry out a strategic review earlier this year, after receiving a number of expressions of interest for the business, reports Reuters. (Reuters) […]

Seagrave Leaves JP Morgan to Join Jefferies

James Seagrave joined Jefferies as an MD in the global financial sponsors investment banking group. He will be based in London and will focus on coverage of UK based financial sponsors. Prior to this, Seagrave spent his whole career at J.P. Morgan where he recently was an MD in their financial sponsors coverage group.

CMEA, Redpoint and USVP Look to Cash in on Intermolecular’s IPO

(Reuters) – Intermolecular Inc. filed with U.S. regulators on Friday to raise $200 million in an initial public offering of its common stock. The company develops proprietary technology and intellectual property through paid collaborative development programs with its customers in the semiconductor and clean energy industries. Intermolecular said in its S-1 filing that it has […]

CardioDx Seals $60M in Equity Financing

CardioDx, a company developing cardiovascular genomic diagnostics, has raised $60 million in new equity funding. New investors Longitude Capital, J.P. Morgan, Acadia Woods Partners, Artiman Ventures, and Bright Capital, the venture arm of RU-COM, participated in the round, which also included the company’s previous investors. The company has raised money previously from Kleiner, Perkins, Caufield & Byers, Mohr Davidow Ventures, TPG Biotech, Intel Capital, Pappas Ventures, DAG Ventures, Asset Management Group and GE Capital. Funding will be used to expand reimbursement coverage in the United States for the company’s blood-based gene expression test for obstructive coronary artery disease, as well as to continue development of future products. The company, based in Palo Alto, Calif., closed a $45 million round in May 2010.

Reuters: Buyout Firms Face More Scrutiny in Asia

HONG KONG (Reuters) – Private equity transactions in the financial sector across Asia are receiving heavier scrutiny from regulators worried about handing control of a regulated entity to a foreign buyout firm. A panel of financial institutions’ M&A bankers, speaking at the Reuters Global M&A summit in Hong Kong on Wednesday, cited the increased attention […]

PEHUB Community

Join the 12505 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget

Reuters VC and PE feed

RSS Feed Widget